why do glp 1 cause fatigue does Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Why Do GLP-1 Medications Cause

GLP-1 agonists may: Optimize high-risk patients before surgery Improve metabolic control Potentially reduce surgical risk But durable long-term outcomes in severe obesity still rely heavily on: Surgical intervention Lifelong follow-up Nutritional monitoring Multidisciplinary care The future may not be medicine vs surgery. It may be the intelligent integration of both

Bariatric surgery induces weight loss and can trigger remission of type 2 diabetes mellitus (T2DM) but may also lead to post-bariatric hypoglycaemia

GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D2

Joel Habener, Lotte Bjerre Knudsen, Svetlana Mojsov

GLP-1GLP-1GLP-1GLP-1

The GLP-1 arena is currently dominated by two giants, Novo Nordisk and Eli Lilly, forming a duopoly in this high-growth field